Treatment of Type2 Diabetes
-
Could Early Intensive Insulin Therapy be a Breakthrough T2D Treatment?
I have long been frustrated that ADA Guidelines still have insulin therapy as the last step in its Diabetes Standards…
Read More » -
Using AI to Find High-Risk Patients for T2 Diabetes Could Save Billions and Extend Lives
We spoke with Chaitanya Mamillapalli, MD, MRCP, FAPCR, Endocrinologist (bio) with the Springfield Clinic a 400 physician multi-specialty organization with…
Read More » -
Is Zero Card the Future of Better Care?
We spoke with Stanley N. Schwartz, MD, FACP, and Chief Medical Officer of Zero Card — https://www.thezerocard.com/ — about why…
Read More » -
New Effective Drug for Kids and Teens with T2D
We spoke with William Tamborlane, MD, (bio) Professor of Pediatrics (Endocrinology); Chief, Pediatric Endocrinology at Yale School of Medicine about…
Read More » -
The Biggest Diabetes Coaching Firm You Don’t Know
We spoke with David Weingard, CEO of Cecelia Health — www.ceceliahealth.com. This New York-based firm employs CDEs to coach people…
Read More » -
SGLT2 Inhibitors Proving Powerful for T2D; Important for Younger Patients?
We spoke with Naveed Sattar, MD, PhD with the University of Glasgow, Scotland about the Credence Study and its…
Read More » -
Cardiologist Education Key to Adoption of Advanced T2D Drugs
We corresponded with Felona Gunawan, MD (bio) from the endocrinology department at the Yale School of Medicine and Yale-New Haven…
Read More » -
Is Muscle Mass the Fountain of Youth?
We spoke with Angelique (Angie) Brellenthin, a postdoctoral researcher in kinesiology at Iowa State University and co-author of a new…
Read More » -
ADA Updates Standards to include Vascepa for T2D Cardio Care
For 2019, the ADA updated Section 10 of its Standards of Care based on the published results of the REDUCE-IT study,…
Read More » -
A1c Not Reliable in Diagnosing T2D
“Based on our findings, A1c should not be solely used to determine the prevalence of diabetes,” said lead researcher Maria…
Read More »
